CLINICAL EVALUATION OF MK-185 - NEW HYPOLIPIDEMIC DRUG

被引:24
作者
SIRTORI, C
SABIH, K
AZARNOFF, DL
HURWITZ, A
机构
关键词
D O I
10.1007/BF02532594
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:96 / &
相关论文
共 7 条
[1]  
AZARNOFF DL, 1962, J LAB CLIN MED, V60, P331
[2]  
DIXON WJ, 1969, INTRO STATISTICAL AN
[3]   FAT TRANSPORT IN LIPOPROTEINS - AN INTEGRATED APPROACH TO MECHANISMS AND DISORDERS (CONTINUED) [J].
FREDRICK.DS ;
LEVY, RI ;
LEES, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (03) :148-+
[4]  
JAIN A, 1970, CLIN PHARMACOL THER, V11, P551
[5]   COMPARISON OF LIPOPROTEIN ANALYSIS BY AGAROSE GEL AND PAPER ELECTROPHORESIS WITH ANALYTICAL ULTRACENTRIFUGATION [J].
NOBLE, RP ;
HATCH, FT ;
MAZRIMAS, JA ;
LINDGREN, FT ;
JENSEN, LC ;
ADAMSON, GL .
LIPIDS, 1969, 4 (01) :55-&
[6]   PHENOTYPING OF TYPE-II AND IV HYPERLIPOPROTEINEMIAS BY A SIMPLE, QUANTITATIVE AGAROSE GEL LIPOPROTEIN ELECTROPHORESIS [J].
SIRTORI, C ;
HASSANEIN, KM ;
HASSANEIN, R ;
BOULOS, BM .
CLINICA CHIMICA ACTA, 1971, 31 (02) :305-+
[7]  
WALTER D, 1969, TECHNICON S AUTOMATI, P365